DR. DAVID W OLDACH, M.D.
Osteopathic Medicine at Greene St, Baltimore, MD

License number
Maryland D37923
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address
22 S Greene St, Baltimore, MD 21201
Phone
(410) 328-5793
(410) 328-0248 (Fax)

Personal information

See more information about DAVID W OLDACH at radaris.com
Name
Address
Phone
David W Oldach, age 66
602 Bend Rd, Towson, MD 21229
(410) 825-6508
David W Oldach, age 66
602 Bend Rd, Towson, MD 21204
(410) 825-6508
David Oldach
419 Redwood St, Baltimore, MD 21201
(410) 328-5196
David W Oldach, age 67
10 Burnbrae Rd, Towson, MD 21204
(410) 825-6508
(410) 825-4208
David Oldach
419 Redwood, Street, MD 21201
(410) 328-5196

Professional information

See more information about DAVID W OLDACH at trustoria.com
David W Oldach Photo 1
David W Oldach, Baltimore MD

David W Oldach, Baltimore MD

Specialties:
Infectious Disease Specialist
Address:
22 S Greene St, Baltimore, MD 21201
Education:
University of Maryland, School of Medicine - Doctor of Medicine
Johns Hopkins Hospital - Fellowship - Infectious Disease (Internal Medicine)
Massachusetts General Hospital - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Infectious Disease (Internal Medicine)


David W Oldach Photo 2
Dr. David W Oldach, Baltimore MD - MD (Doctor of Medicine)

Dr. David W Oldach, Baltimore MD - MD (Doctor of Medicine)

Specialties:
Infectious Disease Medicine
Address:
22 S Greene St, Baltimore 21201
(410) 328-5793 (Phone), (410) 328-0248 (Fax)
Baltimore Office
22 S Greene St, Baltimore 21201
(410) 328-6971 (Phone), (410) 328-8326 (Fax)
Certifications:
Infectious Disease, 1992, Internal Medicine, 1989
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
22 S Greene St, Baltimore 21201
Baltimore Office
22 S Greene St, Baltimore 21201
University of Maryland Medical Center
22 South Greene St, Baltimore 21201
Education:
Medical School
University of Maryland At Baltimore / Professional Schools
Graduated: 1986
Mass Genl Hosp
The Johns Hopkins Hospital


David Oldach Photo 3
Synergistic Combinations Of Guanosine Analog Reverse Transcriptase Inhibitors And Inosine Monophosphate Dehydrogenese Inhibitors And Uses Therefor

Synergistic Combinations Of Guanosine Analog Reverse Transcriptase Inhibitors And Inosine Monophosphate Dehydrogenese Inhibitors And Uses Therefor

US Patent:
6514979, Feb 4, 2003
Filed:
Mar 3, 1999
Appl. No.:
09/261712
Inventors:
David Margolis - Baltimore MD
Alonso Heredia - Washington DC
David Oldach - Towson MD
Robert Redfield - Baltimore MD
Assignee:
University of Maryland Biotechnology Institute - College Park MD
International Classification:
A61K 3152
US Classification:
514261, 514266, 514470
Abstract:
Synergistic combinations of guanosine nucleoside analog reverse transcriptase inhibitors such as abacavir with inosine monophosphate dehydrogenase inhibitors such as mycophenolates, pharmaceutical compositions comprising such combinations, and therapeutic methods comprising administering the synergistic combinations to subjects in need thereof, for treating a viral infection, such as an HIV-1 infection.


David Oldach Photo 4
David Oldach

David Oldach

Location:
Baltimore, Maryland Area
Industry:
Biotechnology


David Oldach Photo 5
Methods For Treating Hcv

Methods For Treating Hcv

US Patent:
2013027, Oct 17, 2013
Filed:
Dec 8, 2011
Appl. No.:
13/995797
Inventors:
William E. Delaney - Foster City CA, US
John O. Link - San Francisco CA, US
Hongmei Mo - Palo Alto CA, US
David W. Oldach - Towson MD, US
Adrian S. Ray - Redwood City CA, US
William J. Watkins - Saratoga CA, US
Cheng Yong Yang - Foster City CA, US
Weidong Zhong - San Ramon CA, US
Assignee:
GILEAD SCIENCES, INC. - Foster City CA
International Classification:
A61K 31/501, A61K 31/5377, A61K 31/7056, A61K 31/4184, A61K 38/21, A61K 31/675, A61K 31/381
US Classification:
424 857, 514 80, 5142352, 514 43
Abstract:
This invention relates to combinations of therapeutic molecules useful for treating hepatitis C virus infection. The present invention relates to methods, uses, dosing regimens, and compositions.